AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS
2020-07-04
عنوان الدراسة
AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS
داعم الدراسة
Roche
دواء الدراسة
Ocrelizumab
رقم بروتوكول الدراسة
MN39159
حالة الدراسة
Terminated
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.